High-dose cyclophosphamide for retractory autoimmnune hemolytic anemia

Blood

Volumn 100, Issue 2, 2002, Pages 704-706

  Moyo, Victor M ^a,b   Smith, Douglas ^a,b   Brodsky, Isadora ^a,b   Crilley, Pamela ^a,b   Jones, Richard J ^a,b   Brodsky, Robert A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Bunting Blaustein Cancer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MESNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LEUKOCYTE COUNT; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; REFRACTORY ANEMIA; RELAPSE; REMISSION; SCHOOL CHILD; SPLENECTOMY;

EID: 0037100518     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0087     Document Type: Article

References (18)

1. Rationale for the use of cyclophosphamide as an immunosuppressant for marrow transplants in man
2. Aplastic anaemia treated by marrow transplantation
3. Assessment of aldehyde dehydrogenase in viable cells
4. Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide
5. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia
6. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children
7. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease
8. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease
9. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris
10. Elimination of alloantibodies by immunoablative high-dose cyclophosphamide
11. Autoimmune hemolytic anemias
12. Management of autoimmune hemolytic anemias
13. Danazol therapy for autoimmune hemolytic anemia
14. Idiopathic acquired autoimmune hemolytic anemia: A review of fortyseven cases treated from 1955 through 1965
15. Challenges in managing autoimmune disease
16. Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease
17. Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia
18. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients